CompaniesChronTech Pharma

ChronTech Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

195

By Phase

PHASE1/PHASE2: 2PHASE1: 2PHASE2: 1

By Status

RECRUITING: 2UNKNOWN: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT05950165
Hover over trial bars to see details

Recent Trials

NCT07049458Lead Sponsor
Study of CHO-A04 in Advanced Solid Tumors
PHASE1/PHASE2Not yet recruiting
62 participants
Started: Dec 1, 2025 · Completed: Oct 1, 2028
NCT07016152Lead Sponsor
An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults
PHASE1Recruiting
40 participants
Started: Jun 26, 2025 · Completed: Apr 10, 2027
NCT05950165Lead Sponsor
A Study to Assess Safety and Efficacy of CHO-H01 As a Single Agent/Combined with Lenalidomide in Subjects with Refractory or Relapsed Non-Hodgkin's Lymphoma
PHASE1/PHASE2Recruiting
37 participants
Started: Jan 15, 2020 · Completed: Dec 23, 2026
NCT03221348Lead Sponsor
A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma
PHASE1Unknown
24 participants
Started: Mar 31, 2018 · Completed: Nov 30, 2019
NCT01335711Lead Sponsor
CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects
PHASE2Unknown
32 participants
Started: Apr 30, 2011 · Completed: Jun 30, 2012